Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-216759
Filing Date
2026-05-11
Accepted
2026-05-11 16:08:46
Documents
65
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sepn-20260331.htm   iXBRL 10-Q 2663765
2 EX-10.1 sepn-ex10_1.htm EX-10.1 38418
3 EX-31.1 sepn-ex31_1.htm EX-31.1 19979
4 EX-31.2 sepn-ex31_2.htm EX-31.2 19378
5 EX-32.1 sepn-ex32_1.htm EX-32.1 17253
6 GRAPHIC img191903475_0.jpg GRAPHIC 216123
  Complete submission text file 0001193125-26-216759.txt   10307383

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20260331.xsd EX-101.SCH 1232481
69 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20260331_htm.xml XML 1768842
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42382 | Film No.: 26963240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)